Literature DB >> 32343794

Bendamustine-induced immune hemolytic anemia: a case report and systematic review of the literature.

Maverick Chan1, William K Silverstein2, Anna Nikonova1, Katerina Pavenski1,2,3, Lisa K Hicks1,2,4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32343794      PMCID： PMC7189296          DOI： 10.1182/bloodadvances.2020001726

Source DB:  PubMed          Journal:  Blood Adv        ISSN： 2473-9529


× No keyword cloud information.
  19 in total

1.  Guidelines on the management of drug-induced immune and secondary autoimmune, haemolytic anaemia.

Authors:  Quentin A Hill; Robert Stamps; Edwin Massey; John D Grainger; Drew Provan; Anita Hill
Journal:  Br J Haematol       Date:  2017-04-03       Impact factor: 6.998

2.  Drug induced immune haemolytic anaemia in the Berlin Case-Control Surveillance Study.

Authors:  Edeltraut Garbe; Frank Andersohn; Elisabeth Bronder; Andreas Klimpel; Michael Thomae; Hubert Schrezenmeier; Martin Hildebrandt; Ernst Späth-Schwalbe; Andreas Grüneisen; Beate Mayer; Abdulgabar Salama; Hanife Kurtal
Journal:  Br J Haematol       Date:  2011-07-12       Impact factor: 6.998

Review 3.  IVIG in autoimmune disease - Potential next generation biologics.

Authors:  Adrian W Zuercher; Rolf Spirig; Adriana Baz Morelli; Fabian Käsermann
Journal:  Autoimmun Rev       Date:  2016-03-25       Impact factor: 9.754

Review 4.  Bendamustine-induced immune hemolytic anemia in a chronic lymphocytic leukemia patient: A case report and review of the literature.

Authors:  Housam Haddad; Farhan Mohammad; Qun Dai
Journal:  Hematol Oncol Stem Cell Ther       Date:  2014-04-29

5.  Bendamustine combined with rituximab in patients with relapsed and/or refractory chronic lymphocytic leukemia: a multicenter phase II trial of the German Chronic Lymphocytic Leukemia Study Group.

Authors:  Kirsten Fischer; Paula Cramer; Raymonde Busch; Stephan Stilgenbauer; Jasmin Bahlo; Carmen D Schweighofer; Sebastian Böttcher; Peter Staib; Michael Kiehl; Michael J Eckart; Gabriele Kranz; Valentin Goede; Thomas Elter; Andreas Bühler; Dirk Winkler; Michael Kneba; Hartmut Döhner; Barbara F Eichhorst; Michael Hallek; Clemens-Martin Wendtner
Journal:  J Clin Oncol       Date:  2011-08-15       Impact factor: 44.544

Review 6.  Drug-induced immune hemolytic anemia.

Authors:  Abdulgabar Salama
Journal:  Expert Opin Drug Saf       Date:  2009-01       Impact factor: 4.250

Review 7.  Splenic marginal-zone lymphoma: a distinct clinical and pathological entity.

Authors:  Catherine Thieblemont; Pascale Felman; Evelyne Callet-Bauchu; Alexandra Traverse-Glehen; Gilles Salles; Françoise Berger; Bertrand Coiffier
Journal:  Lancet Oncol       Date:  2003-02       Impact factor: 41.316

8.  Bendamustine-associated hemolytic anemia.

Authors:  Lisa E Glance; Aaron Cumpston; Abraham Kanate; Scot C Remick
Journal:  Ann Pharmacother       Date:  2009-10-06       Impact factor: 3.154

9.  Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.

Authors:  David Moher; Alessandro Liberati; Jennifer Tetzlaff; Douglas G Altman
Journal:  PLoS Med       Date:  2009-07-21       Impact factor: 11.069

10.  Recurrent autoimmune hemolytic anemia in splenic marginal zone lymphoma.

Authors:  Oreoluwa Oladiran; Rashmi Dhital; Anthony Donato
Journal:  J Community Hosp Intern Med Perspect       Date:  2018-08-23
View more
  2 in total

1.  Case Report: First Case of Cefotaxime-Sulbactam-Induced Acute Intravascular Hemolysis in a Newborn With ABO Blood Type Incompatibility by the Mechanism of Non-Immunologic Protein Adsorption.

Authors:  Yuanjun Wu; Yong Wu; Yong Yang; Baochan Chen; Jianqun Li; Ganping Guo; Fu Xiong
Journal:  Front Immunol       Date:  2021-12-22       Impact factor: 7.561

Review 2.  Bendamustine: A review of pharmacology, clinical use and immunological effects (Review).

Authors:  Hrvoje Lalic; Igor Aurer; Drago Batinic; Dora Visnjic; Tomislav Smoljo; Antonija Babic
Journal:  Oncol Rep       Date:  2022-05-04       Impact factor: 4.136
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.